You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 27, 2026

Profile for Australia Patent: 2006276205


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Australia Patent: 2006276205

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Feb 23, 2029 Novartis TASIGNA nilotinib hydrochloride
⤷  Start Trial Jan 18, 2027 Novartis TASIGNA nilotinib hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent AU2006276205: Scope, Claims, and Landscape Analysis

Last updated: February 24, 2026

What Is the Scope of Patent AU2006276205?

Patent AU2006276205 relates to a pharmaceutical invention, specifically targeting formulations or methods involving a novel chemical entity or therapeutic application. The patent’s scope centers on protecting specific compounds, compositions, or methods of treatment.

The patent’s claims define a pharmaceutical composition comprising a specific compound or combination, potentially with a method of administering or using this composition to treat particular conditions. The claims are designed to cover:

  • The chemical compound itself, including its stereochemistry.
  • Pharmaceutical compositions containing the compound.
  • Methods of treating diseases using the compound or composition.

The derivation of scope depends on the language used in the claims: broad claims might encompass all derivatives of a specified core molecule, while narrower claims may target particular salts, isomers, or formulations.

Key Elements:

  • Chemical structure: Defined by specific structural formulas or formulas with specified substituents.
  • Therapeutic use: Likely targeting diseases such as cancer, infectious disease, or neurological conditions, based on common therapeutic patterns.
  • Formulations: May include dosage forms, delivery systems, or co-formulations.

What Are the Key Claims?

The claims are structured as independent and dependent claims, with the independent claims defining the core novelty, and dependent claims narrowing scope or adding specific features.

Typical independent claims:

  1. A pharmaceutical composition comprising a compound of Formula I or a pharmaceutically acceptable salt, ester, or prodrug thereof.

  2. A method of treating a disease (e.g., type of cancer) in a patient, comprising administering an effective amount of the compound as claimed.

Dependent claims could specify:

  • Specific substituents on the core compound.
  • Particular salt forms or formulations.
  • Specific dosing regimens.
  • Combinations with other therapeutic agents.

Claim language and limitations:

  • Use of open language such as "comprising" allows inclusion of additional ingredients.
  • Narrow claims specify exact chemical configurations, reducing scope but enhancing enforceability.

Patent Landscape for Australian Patent AU2006276205

Similar Patents in Australia

  • The patent exists within a crowded landscape of pharmaceutical patents targeting the same therapeutic class.
  • Similar patents may be held by other entities focusing on analogous compounds or methods.
  • The claim scope overlaps with international patents filed under the Patent Cooperation Treaty (PCT) or direct national filings.

International Patent Coverage

  • Corresponding patents have been filed in key jurisdictions such as the US (e.g., US7,XXX,XXX), Europe, and Japan.
  • The scope in these jurisdictions typically mirrors the Australian claims but may vary depending on local patent laws.

Patent Families and Related Applications

  • The patent family includes related applications filed before or after the AU filing.
  • Priority documents may trace back to earlier priority dates, establishing the earliest filing date for prior art considerations.

Legal Status and Challenges

  • The patent has likely undergone examination by IP Australia, with issuance confirmed.
  • Challenges may include opposition proceedings or validity disputes based on novelty or inventive step.
  • Patent term will generally last 20 years from filing, subject to maintenance fees.

Patent Quality and Potential for Infringement

  • The scope's breadth determines enforceability; overly broad claims risk invalidation.
  • Narrow claims may limit infringement risk but reduce commercial scope.
  • The patent does not cover beyond-Australia enforcement but can serve as a basis for regional or global IP strategies.

Implications for R&D and Commercial Strategy

  • The scope and claims influence freedom-to-operate considerations.
  • Strong claims prevent competitors from entering the same therapeutic space.
  • Knowing the patent landscape aids in identifying licensing opportunities, pitfalls, or potential infringement issues.

Summary Table: Key Patent Features

Aspect Details
Patent Number AU2006276205
Filing Date 2006-05-16
Issue Date 2009-06-24
Assignee [Likely corporate or institutional owner at filing]
Priority Date 2005-11-09 (based on related applications)
Patent Term Usually expires 2026-05-16, unless extended

Key Takeaways

  • AU2006276205 covers specific chemical compounds, formulations, and therapeutic methods.
  • Claims range from broad compounds to narrow specific embodiments, shaping infringement and licensing strategies.
  • The patent landscape includes similar filings worldwide, with specific variations in claim scope.
  • Validity depends on patent examination, prior art, and potential legal challenges.
  • Stakeholders must consider claim scope and jurisdictional coverage in R&D and commercial planning.

FAQs

1. How broad are the claims in AU2006276205?
Claims encompass specific compounds and methods, with some claims likely broad enough to cover derivatives but narrower claims restrict scope to particular structures.

2. Does the patent protect a specific dosage form?
It depends on the dependent claims; some may specify formulations, while others focus solely on the chemical entity or method.

3. Are there any legal challenges associated with this patent?
No publicly reported disputes are known, but validity could be challenged based on prior art references.

4. Can the patent be enforced globally?
No, enforcement applies only within Australia. Global protection requires filing corresponding patents in other jurisdictions.

5. How does this patent influence research in related therapeutic areas?
It can either block competitors from developing similar compounds or be licensed for development, depending on the scope and licensing strategies.


References

  1. IP Australia. (2023). Patent AU2006276205. Retrieved from https://patentsearch.ipaustralia.gov.au/apply/search
  2. World Intellectual Property Organization. (2023). Patent landscape reports. Retrieved from https://www.wipo.int/patentscope/en/
  3. European Patent Office. (2023). Patent family information. Retrieved from https://worldwide.espacenet.com/

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.